Cargando…
Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy
Standard cancer chemotherapeutics often produce significant adverse effects and eventually lose their effectiveness due to the emergence of resistance mechanisms. As a result, patients with malignant tumors experience a poor quality of life and a short lifespan. Thus, combination medication regimens...
Autores principales: | Afshari, Amir R., Sanati, Mehdi, Kesharwani, Prashant, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455605/ https://www.ncbi.nlm.nih.gov/pubmed/37623653 http://dx.doi.org/10.3390/jfb14080408 |
Ejemplares similares
-
Effects of curcumin on low-density lipoprotein oxidation: From experimental studies to clinical practice
por: Baratzadeh, Fatemeh, et al.
Publicado: (2022) -
Berberine: Ins and outs of a nature-made PCSK9 inhibitor
por: Ataei, Sarina, et al.
Publicado: (2022) -
Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
por: Mukherjee, Anubhab, et al.
Publicado: (2020) -
Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis
por: Kesharwani, Prashant, et al.
Publicado: (2022) -
Recent advances of bioresponsive polymeric nanomedicine for cancer therapy
por: Hong, Tu, et al.
Publicado: (2022)